By Cytiva
Published in: Cell & Gene
Published on: January 12, 2022
Introduction: Cell therapies are changing the landscape of clinical care, and their temperature-related vulnerability has made continuous cold chain management even more critical in the delivery of treatments to patients.
Cold chain management comprises three key phases: cooling, storage, and thawing. Thawing errors for a potentially lifesaving therapy could compromise treatment efficacy and may have significant impact on patients, costs, and a product developer’s reputation.
